Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...
Read Full NewsDavid Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.
Friedberg explains how an emphasis on physical fitness prior to and after surgery can significantly better long-term outcomes.
Bakhos explains the ideal patient population and strategies inherent to LVRS success.
The chief medical officer at the Parkinson’s Foundation detailed how mood and behavioral symptoms shape quality of life in Parkinson disease and how clinicians can better identify and manage them.
IntraBio reported that levacetylleucine showed symptom improvement in the phase 3 IB1001-303 study for ataxia-telangiectasia, and it intends to proceed with regulatory submissions in multiple regions.
A Phase 1 study in healthy lactating women found that a single 10‑mg dose of zavegepant nasal spray was generally safe, well tolerated, and resulted in minimal infant exposure through breast milk.
Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.
1.
Chemo causes lasting physical decline in breast cancer survivors
2.
The FDA Approves the New Frontline Aggressive ALL Regimen.
3.
Many patients learn they could have cancer in the emergency department
4.
Recent research suggests that vitamin supplements may increase the risk of developing cancer.
5.
Guidelines for cervical cancer screening and the risk of preterm birth in young women.
1.
Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies
2.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions
5.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge